Optiver Holding
GSK icon

Optiver Holding’s GSK GSK Stock Holding History

Optiver Holding’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Sell
182,600
-31,500
-15% -$1.71M ﹤0.01% 357
2025
Q4 		$10.5M Buy
214,100
+2,400
+1% +$112K ﹤0.01% 327
2025
Q3 		$9.14M Sell
211,700
-27,500
-11% -$1.07M ﹤0.01% 299
2025
Q2 		$9.19M Sell
239,200
-89,200
-27% -$3.41M ﹤0.01% 184
2025
Q1 		$12.7M Sell
328,400
-157,000
-32% -$5.75M 0.01% 159
2024
Q4 		$16.4M Buy
485,400
+56,200
+13% +$2.02M 0.01% 163
2024
Q3 		$17.5M Sell
429,200
-105,200
-20% -$4.3M 0.01% 193
2024
Q2 		$20.6M Sell
534,400
-302,500
-36% -$12.7M 0.01% 210
2024
Q1 		$36.1M Sell
836,900
-90,300
-10% -$3.72M 0.02% 174
2023
Q4 		$34.2M Buy
927,200
+16,200
+2% +$582K 0.02% 177
2023
Q3 		$33.2M Sell
911,000
-79,800
-8% -$2.83M 0.02% 184
2023
Q2 		$35M Buy
990,800
+12,600
+1% +$452K 0.02% 182
2023
Q1 		$34.5M Buy
978,200
+425,100
+77% +$14.9M 0.03% 194
2022
Q4 		$19.2M Buy
553,100
+119,300
+28% +$3.97M 0.02% 191
2022
Q3 		$12.6M Sell
433,800
-450,840
-51% -$17.1M 0.01% 176
2022
Q2 		$47.6M Sell
884,640
-79,200
-8% -$4.37M 0.05% 78
2022
Q1 		$52.5M Buy
963,840
+199,360
+26% +$10.8M 0.05% 72
2021
Q4 		$37.7M Buy
764,480
+223,280
+41% +$11.6M 0.03% 108
2021
Q3 		$25.6M Sell
541,200
-134,640
-20% -$6.76M 0.03% 97
2021
Q2 		$33.6M Buy
+675,840
New +$32.5M 0.05% 73
2021
Q1 		– Hold
0
– – – 73

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Optiver Holding's GSK Position: Q1 2026 in Review

Optiver Holding reduced its GSK (GSK) stake by 28% in Q1 2026, selling an estimated $5.47M and leaving 255,274 shares worth $14.1M. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Optiver Holding first reported a position in GSK in Q4 2021 and has held it in 8 quarters since. The position peaked at $38.7M in Q4 2023. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Optiver Holding held 255,274 shares of GSK worth $14.1M as of Q1 2026.
  • Optiver Holding sold 100,946 GSK shares in Q1 2026, an estimated $5.47M.
  • GSK made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #319 holding.
  • Optiver Holding first reported a position in GSK in Q4 2021 and has held it in 8 quarters since.
  • Optiver Holding's GSK position peaked at $38.7M in Q4 2023.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.